Xenon anaesthesia may preserve cardiovascular function in patients with heart failure

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 6, 2005, Pages 743-749

  Baumert, Jan H ^a   Falter, F ^a   Eletr, D ^a   Hecker, K E ^a   Reyle Hahn, M ^a   Rossaint, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cardiovascular function; Xenon

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETOMIDATE; NITRIC ACID DERIVATIVE; OXYGEN; PROPOFOL; REMIFENTANIL; XENON;

ADULT; AGED; ANESTHESIA COMPLICATION; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

AGED; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR PHYSIOLOGY; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MYOCARDIAL ISCHEMIA; PROSTHESIS IMPLANTATION; SINGLE-BLIND METHOD; XENON;

EID: 21744446080     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2005.00662.x     Document Type: Article

References (37)

1. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9.
2. Lehmann A, Boldt J, Zeitler C, Thaler E, Werling C. Total intravenous anesthesia with remifentanil and propofol for implantation of cardioverter-defibrillators in patients with severely reduced left ventricular function. J Cardiothorac Vasc Anesth 1999; 13: 15-9.
3. Mutch WA, White IW, Donen N, Thomson IR, Rosenbloom M, Cheang M et al. Haemodynamic instability and myocardial ischaemia during carotid endarterectomy. a comparison of propofol and isoflurane. Can J Anaesth 1995; 42: 577-87.
4. Mylos PS, Buckland MR, Weeks AM, Bujor MA, McRae R, Langley M et al. Hemodynamic effects, myocardial ischemia, and timing of tracheal oxtubation with propofol-based anesthesia for cardiac surgery. Anesth Analg 1997; 84: 12-9.
5. Lachmann B, Armbruster S, Schairer W, Landstra M, Trouwborst A, Van Daal GJ et al. Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 1990; 335: 1413-5.
6. Rossaint R, Reyle-Hahn M, Schulte am Esch J, Scholz J, Scherpereel P, Vallet B et al. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003; 98: 6-13.
7. Perez JE, Waggoner AD, Barzilai B, Melton HE, Miller JG, Sobel BE. On-line assessment of ventricular function by automatic boundary detection and ultrasonic backscatter imaging. J Am College Cardiol 1992; 19: 313-20.
8. Perez JE, Klein SC, Prater DM, Fraser CE, Cardona H, Waggoner AD et al. Automated, on-line quantification of left ventricular dimensions and function by echocardiography with backscatter imaging and lateral gain compensation. Am J Cardiol 1992; 70: 1200-5.
9. Gorcsan J III, Gasior TA, Mandarino WA, Deneault LG, Hattler BG, Pinsky MR. On-line estimation of changes in left ventricular stroke Volume by transesophageal echocardiographic automated border detection in patients undergoing coronary artery bypass grafting. Am J Cardiol 1993; 72: 721-7.
10. Stoddard MF, Keedy DL, Longaker RA. Two-dimensional transesophageal echocardiographic characterization of ventricular filling in real time by acoustic quantification: comparison with pulsed Doppler echocardiography. J Am Soc Echocardiogr 1994; 7: 116-31.
11. Pinto FJ, Siegel LC, Chenzbraun A, Schnittger I. On-line estimation of cardiac output with a new automated border detection system using transesophageal echocardiography: a preliminary comparison with thermodilution. J Cardiothorac Vasc Anesth 1994; 8: 625-30.
12. Greim CA, Roewer N, Schulte am EJ. Assessment of changes in left ventricular wall stress from the end-systolic pressure-area product. Br J Anaesth 1995; 75: 583-7.
13. Wilhelm W, Biedler A, Huppert A, et al. Comparison of the effects of remifentanil or fentanyl on anaesthetic induction characteristics of propofol, thiopental or etomidate. Eur J Anaesthesiol 2002; 19: 350-6.
14. Cheong KF, Choy JM. Sevoflurane-fentanyl versus etomidate-fentanyl for anesthetic induction in coronary artery bypass graft surgery patients. J Cardiothorac Vasc Anesth 2000; 14: 421-4.
15. Vinson DR, Bradbury DR. Etomidate for procedural sedation in emergency medicine. Ann Emerg Med 2002; 39: 592-8.
16. Paris AMD. Activation of [alpha]2B-adrenoceptors mediates the cardiovascular effects of etomidate. Anesthesiology 2003; 99: 889-95.
17. Shinohara K, Aono H, Unruh GK, Kindscher JD, Goto H. Suppressive effects of remifentanil on hemodynamics in baro-denervated rabbits. Can J Anaesth 2000; 47: 361-6.
18. Schuttler J, Albrecht S, Breivik H, Osnes S, Prys-Roberts C, Holder K et al. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997; 52: 307-17.
19. Wodey E, Chonow L, Beneux X, Azzis O, Bansard JY, Ecoffey C. Haemodynamic effects of propofol vs thiopental in infants: an echocardiographic study. Br J Anaesth 1999; 82: 516-20.
20. Williams GD, Jones TK, Hanson KA, Morray JP. The homo-dynamic effects of propofol in children with congenital heart disease. Anesth Analg 1999; 89: 1411-6.
21. Bilotta F, Fiorani L, La RI, Spinelli F, Rosa G. Cardiovascular effects of intravenous propofol administered at two infusion rates: a transthoracic echocardiographic study. Anaesthesia 2001; 56: 266-71.
22. Gare M, Parail A, Milosavljevic D, Kersten JR, Warltier DC, Pagel PS. Conscious sedation with midazolam or propofol does not alter left ventricular diastolic performance in patients with preexisting diastolic dysfunction, a transmitral and tissue Doppler transthoracic echocardiography study. Anesth Analg 2001; 93: 865-71.
23. Meissner A, Weber TP, Van Aken H, Zbieranek K, Rolf N. Recovery from myocardial stunning is faster with desflurane compared with propofol in chronically instrumented dogs. Anesth Analg 2000; 91: 1333-8.
24. Cullen SC, Gross EG. The anesthetic properties of xenon in animals and human beings with additional observations on krypton. Science 1951; 133: 580-2.
25. Cullen SC, Eger EI, Gregory P. Use of xenon and xenon-halothan in a study of basic mechanisms of anesthesia in man. Anesthesiology 1967; 28: 243-4.
26. Boomsma F, Rupreht J, Man in't Veld AJ, de Jong FH, Dzoljic M, Fachmann B. Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia 1990; 45: 273-8.
27. Dingley J, King R, Hughes L, Terblanche C, Mahon S, Hepp M et al. Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia 2001; 56: 829-35.
28. Huneke R, Jungling E, Skasa M, Rossaint R, Luckhoff A. Effects of the anesthetic gases xenon, halothane, and isoflurane on calcium and potassium currents in human atrial cardiomyocytes. Anesthesiology 2001; 95: 999-1006.
29. Schroth SC, Schotten U, Alkanoglu O, Reyle-Hahn MS, Hanrath P, Rossaint R. Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation. Anesthesiology 2002; 96: 422-7.
30. Nakayama H, Takahashi H, Okubo N, Miyabe M, Toyooka H. Xenon and nitrous oxide do not depress cardiac function in an isolated rat heart model. Can J Annesth 2002; 49: 375-9.
31. Preckel B, Schlack W, Heibel T, Rutten H. Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function. Br J Anaesth 2002; 88: 264-9.
32. Hettrick DA, Pagel PS, Kersten JR, Tessmer JP, Bosnjak ZJ, Georgieff M et al. Cardiovascular effects of xenon in isoflurane-anesthetized dogs with dilated cardiomyopathy. Anesthesiology 1998; 89: 1166-73.
33. Preckel B, Mullenheim J, Moloschavij A, Thamer V, Schlack W. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91: 1327-32.
34. Picker O, Schindler AW, Schwarte LA, Preckel B, Schlack W, Scheeren TW et al. Xenon increases total body oxygen consumption during isoflurane anaesthesia in dogs. Br J Anaesth 2002; 88: 546-54.
35. Preckel B, Ebel D, Mullenheim J, Frabetadorf J, Thamer V, Schlack W. The direct myocardial effects of xenon in the dog heart in vivo. Anesth Analg 2002; 94: 545-51.
36. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 1993; 48: 1045-9.
37. Ishiguro Y, Goto T, Nakata Y, Terui K, Niimi Y, Morita S. Effect of xenon on autonomic cardiovascular control - comparison with isoflurane and nitrous oxide. J Clin Anesthesia 2000; 12: 196-201.